Advertisement

Current Reviews in Musculoskeletal Medicine

, Volume 11, Issue 4, pp 583–592 | Cite as

Clinical Update: Why PRP Should Be Your First Choice for Injection Therapy in Treating Osteoarthritis of the Knee

  • Corey S. Cook
  • Patrick A. SmithEmail author
Protein-Rich Plasma: From Bench to Treatment of Arthritis (S Choate and J Tokish, section editors)
Part of the following topical collections:
  1. Topical Collection on Protein-Rich Plasma: From Bench to Treatment of Arthritis

Abstract

Purpose of Review

The purpose of this review is to update the reader on the current applications of platelet-rich plasma (PRP) in the treatment of knee osteoarthritis (KOA). This review will focus on PRP’s effect on the osteoarthritic joint, how PRP compares to traditional treatments of KOA, and provide clinical feedback on the use of PRP in an orthopedic and sports medicine practice.

Recent Findings

Recent research into the applications of PRP for KOA has further indicated both the efficacy and safety of PRP treatment. Although research has shown a tendency toward better efficacy at earlier stages of osteoarthritis (OA), evidence exists to indicate positive effects at all stages of OA.

Summary

In summary, since KOA is an extremely prevalent condition that can be a challenge to treat, it is imperative that safe and effective nonoperative treatment methods be available to individuals that are suffering from this condition.

Keywords

Knee Osteoarthritis PRP Platelet-rich plasma Intra-articular 

Notes

Compliance with Ethical Standards

Conflict of Interest

Dr. Smith is a consultant for Arthrex and receives research support from them.

Dr. Cook has no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Cisternas M, Murphy L, Sacks J, Solomon D, Pasta D, Helmick C. Alternative methods for defining osteoarthritis and the impact on estimating prevalence in a US population-based survey. Arthritis Care Res. 2016;68:574–80.  https://doi.org/10.1002/acr.22721.CrossRefGoogle Scholar
  2. 2.
    Sibille K, Chen H, Bartley E, Riley J, Glover T, King C, et al. Accelerated aging in adults with knee osteoarthritis pain. Pain Rep. 2017;2:e591.  https://doi.org/10.1097/PR9.0000000000000591.CrossRefGoogle Scholar
  3. 3.
    Torio CM, Moore BJ. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2013: Statistical Brief #204. 2016 May. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006 Feb-. Available from: https://www.ncbi.nlm.nih.gov/books /NBK368492/. Accessed 15 July 2018.
  4. 4.
    Zhao L, Kaye AD, Abd-Elsayed A. Stem cells for the treatment of knee osteoarthritis: a comprehensive review. Pain Physician. 2018;21:229–41.PubMedGoogle Scholar
  5. 5.
    Torstensen TA, Grooten WJA, Østerås H, Heijne A, Harms-Ringdahl K, Äng BO. How does exercise dose affect patients with long-term osteoarthritis of the knee? A study protocol of a randomised controlled trial in Sweden and Norway: the SWENOR Study. BMJ Open. 2018;8:e018471.  https://doi.org/10.1136/bmjopen-2017-018471.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Lai L, Stitik T, Foye P, Georgy J, Patibanda V, Chen B. Use of platelet-rich plasma in intra-articular knee injections for osteoarthritis: a systematic review. PM R. 2015;7:637–48.  https://doi.org/10.1016/j.pmrj.2015.02.003.CrossRefGoogle Scholar
  7. 7.
    Ayhan E. Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthop. 2014;5:351–61.  https://doi.org/10.5312/wjo.v5.i3.351.CrossRefGoogle Scholar
  8. 8.
    Laver L, Marom N, Dnyanesh L, Mei-Dan O, Espregueira-Mendes J, Gobbi A. PRP for degenerative cartilage disease: a systematic review of clinical studies. Cartilage. 2016;8:341–64.  https://doi.org/10.1177/1947603516670709.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Jang S, Kim J, Cha S. Platelet-rich plasma (PRP) injections as an effective treatment for early osteoarthritis. Eur J Orthop Surg Traumatol. 2012;23:573–80.  https://doi.org/10.1007/s00590-012-1037-5.CrossRefPubMedGoogle Scholar
  10. 10.
    Pearle AD, Warren RF, Rodeo SA. Basic science of articular cartilage and osteoarthritis. Clin Sports Med. 2005;24:1–12.  https://doi.org/10.1016/j.csm.2004.08.007.CrossRefPubMedGoogle Scholar
  11. 11.
    Martel-Pelletier J, Boileau C, Pelletier J, Roughley P. Cartilage in normal and osteoarthritis conditions. Best Pract Res Clin Rheumatol. 2008;22:351–84.  https://doi.org/10.1016/j.berh.2008.02.001.CrossRefPubMedGoogle Scholar
  12. 12.
    Moussa M, Lajeunesse D, Hilal G, El Atat O, Haykal G, Serhal R, et al. Platelet rich plasma (PRP) induces chondroprotection via increasing autophagy, anti-inflammatory markers, and decreasing apoptosis in human osteoarthritic cartilage. Exp Cell Res. 2017;352:146–56.  https://doi.org/10.1016/j.yexcr.2017.02.012.CrossRefPubMedGoogle Scholar
  13. 13.
    Murray I, Benke M, Mandelbaum B. Management of knee articular cartilage injuries in athletes: chondroprotection, chondrofacilitation, and resurfacing. Knee Surg Sports Traumatol Arthrosc. 2015;24:1617–26.  https://doi.org/10.1007/s00167-015-3509-8.CrossRefPubMedGoogle Scholar
  14. 14.
    LaPrade R, Dragoo J, Koh J, Murray I, Geeslin A, Chu C. AAOS research symposium updates and consensus. J Am Acad Orthop Surg. 2016;24:e62–78.  https://doi.org/10.5435/JAAOS-D-16-00086.CrossRefPubMedGoogle Scholar
  15. 15.
    Zlotnicki J, Geeslin A, Murray I, Petrigliano F, LaPrade R, Mann B, et al. Biologic treatments for sports injuries II think tank—current concepts, future research, and barriers to advancement, part 3. Orthop J Sports Med. 2016;4:232596711664243.  https://doi.org/10.1177/2325967116642433.CrossRefGoogle Scholar
  16. 16.
    Kanchanatawan W, Arirachakaran A, Chaijenkij K, Prasathaporn N, Boonard M, Piyapittayanun P, et al. Short-term outcomes of platelet-rich plasma injection for treatment of osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc. 2015;24:1665–77.  https://doi.org/10.1007/s00167-015-3784-4.CrossRefGoogle Scholar
  17. 17.
    Campbell K, Erickson B, Saltzman B, Mascarenhas R, Bach B, Cole B, et al. Is local viscosupplementation injection clinically superior to other therapies in the treatment of osteoarthritis of the knee: a systematic review of overlapping meta-analyses. Arthroscopy. 2015;31:2036–2045.e14.  https://doi.org/10.1016/j.arthro.2015.03.030.CrossRefPubMedGoogle Scholar
  18. 18.
    Patil S, McCauley J, Pulido P, Colwell C. How do knee implants perform past the second decade? Nineteen- to 25-year followup of the press-fit condylar design TKA. Clin Orthop Relat Res. 2014;473:135–40.  https://doi.org/10.1007/s11999-014-3792-6.CrossRefPubMedCentralGoogle Scholar
  19. 19.
    Beswick A, Wylde V, Gooberman-Hill R, Blom A, Dieppe P. What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patients. BMJ Open. 2012;2:e000435.  https://doi.org/10.1136/bmjopen-2011-000435.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Walker L, Clement N, Deehan D. Predicting the outcome of total knee arthroplasty using the womac score: a review of the literature. J Knee Surg. 2018.  https://doi.org/10.1055/s-0038-1666866.
  21. 21.
    Zhang W, Robertson J, Jones A, Dieppe P, Doherty M. The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis. 2008;67:1716–23.  https://doi.org/10.1136/ard.2008.092015.CrossRefPubMedGoogle Scholar
  22. 22.
    Wang P, Yang L, Li H, Lei Z, Yang X, Liu C, et al. Effects of whole-body vibration training with quadriceps strengthening exercise on functioning and gait parameters in patients with medial compartment knee osteoarthritis: a randomised controlled preliminary study. Physiotherapy. 2016;102:86–92.  https://doi.org/10.1016/j.physio.2015.03.3720.CrossRefGoogle Scholar
  23. 23.
    Levy D, Petersen K, Scalley Vaught M, Christian D, Cole B. Injections for knee osteoarthritis: corticosteroids, Viscosupplementation, platelet-rich plasma, and autologous stem cells. Arthroscopy. 2018;34:1730–43.  https://doi.org/10.1016/j.arthro.2018.02.022.CrossRefPubMedGoogle Scholar
  24. 24.
    Bennell K, Hunter D, Paterson K. Platelet-rich plasma for the management of hip and knee osteoarthritis. Curr Rheumatol Rep. 2017;19:24.  https://doi.org/10.1007/s11926-017-0652-x.CrossRefPubMedGoogle Scholar
  25. 25.
    Foster T, Puskas B, Mandelbaum B, Gerhardt M, Rodeo S. Platelet-rich plasma. Am J Sports Med. 2009;37:2259–72.  https://doi.org/10.1177/0363546509349921.CrossRefGoogle Scholar
  26. 26.
    Whitney K, Liebowitz A, Bolia I, Chahla J, Ravuri S, Evans T, et al. Current perspectives on biological approaches for osteoarthritis. Ann N Y Acad Sci. 2017;1410:26–43.  https://doi.org/10.1111/nyas.13554.CrossRefPubMedGoogle Scholar
  27. 27.
    Sundman E, Cole B, Karas V, Della Valle C, Tetreault M, Mohammed H, et al. The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis. Am J Sports Med. 2013;42:35–41.  https://doi.org/10.1177/0363546513507766.CrossRefPubMedGoogle Scholar
  28. 28.
    Chahla J, Mandelbaum B. Biological treatment for osteoarthritis of the knee: moving from bench to bedside—current practical concepts. Arthroscopy. 2018;34:1719–29.  https://doi.org/10.1016/j.arthro.2018.01.048.CrossRefPubMedGoogle Scholar
  29. 29.
    Dhurat R, Sukesh M. Principles and methods of preparation of platelet-rich plasma: a review and author’s perspective. J Cutan Aesthet Surg. 2014;7:189–97.  https://doi.org/10.4103/0974-2077.150734.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Machlus K, Thon J, Italiano J. Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation. Br J Haematol. 2014;165:227–36.  https://doi.org/10.1111/bjh.12758.CrossRefPubMedGoogle Scholar
  31. 31.
    Spaková T, Rosocha J, Lacko M, Harvanová D, Gharaibeh A. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil. 2012;91:411–7.  https://doi.org/10.1097/PHM.0b013e3182aab72.CrossRefPubMedGoogle Scholar
  32. 32.
    Sánchez-González D, Méndez-Bolaina E, Trejo-Bahena N. Platelet-rich plasma peptides: key for regeneration. Int J Pept. 2012;2012:1–10.  https://doi.org/10.1155/2012/532519.CrossRefGoogle Scholar
  33. 33.
    Ludwig H, Birdwhistell K, Brainard B, Franklin S. Use of a cyclooxygenase-2 inhibitor does not inhibit platelet activation or growth factor release from platelet-rich plasma. Am J Sports Med. 2017;45:3351–7.  https://doi.org/10.1177/0363546517730578.CrossRefGoogle Scholar
  34. 34.
    Cole B, Seroyer S, Filardo G, Bajaj S, Fortier L. Platelet-rich plasma: where are we now and where are we going? Sports Health. 2010;2:203–10.  https://doi.org/10.1177/1941738110366385.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Watson S, Bahou W, Fitzgerald D, Ouwehand W, Rao A, Leavitt A. Mapping the platelet proteome: a report of the ISTH Platelet Physiology Subcommittee. J Thromb Haemost. 2005;3:2098–101.  https://doi.org/10.1111/j.1538-7836.2005.01550.x.CrossRefPubMedGoogle Scholar
  36. 36.
    Xie X, Zhang C, Tuan R. Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis Res Ther. 2014;16:204.  https://doi.org/10.1186/ar4493.CrossRefGoogle Scholar
  37. 37.
    Khoshbin A, Leroux T, Wasserstein D, Marks P, Theodoropoulos J, Ogilvie-Harris D, et al. The efficacy of platelet-rich plasma in the treatment of symptomatic knee osteoarthritis: a systematic review with quantitative synthesis. Arthroscopy. 2013;29:2037–48.  https://doi.org/10.1016/j.arthro.2013.09.006.CrossRefGoogle Scholar
  38. 38.
    Zhu Y, Yuan M, Meng H, Wang A, Guo Q, Wang Y, et al. Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review. Osteoarthr Cartil. 2013;21:1627–37.  https://doi.org/10.1016/j.joca.2013.07.017.CrossRefPubMedGoogle Scholar
  39. 39.
    Nöth U, Rackwitz L, Heymer A, Weber M, Baumann B, Steinert A, et al. Chondrogenic differentiation of human mesenchymal stem cells in collagen type I hydrogels. J Biomed Mater Res A. 2007;83A:626–35.  https://doi.org/10.1002/jbm.a.31254.CrossRefGoogle Scholar
  40. 40.
    Kon E, Filardo G, Di Martino A, Marcacci M. Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use. Knee Surg Sports Traumatol Arthrosc. 2010;19:516–27.  https://doi.org/10.1007/s00167-010-1306-y.CrossRefPubMedGoogle Scholar
  41. 41.
    Nasi S, Ea H, So A, Busso N. Revisiting the role of interleukin-1 pathway in osteoarthritis: interleukin-1α and -1β, and NLRP3 inflammasome are not involved in the pathological features of the murine menisectomy model of osteoarthritis. Front Pharmacol 2017;8.  https://doi.org/10.3389/fphar.2017.00282.
  42. 42.
    Braun H, Wasterlain A, Dragoo J. The use of PRP in ligament and meniscal healing. Sports Med Arthrosc Rev. 2013;21:206–12.  https://doi.org/10.1097/JSA.0000000000000005.CrossRefPubMedGoogle Scholar
  43. 43.
    Schmidt M, Chen E, Lynch S. A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair. Osteoarthr Cartil. 2006;14:403–12.  https://doi.org/10.1016/j.joca.2005.10.011.CrossRefPubMedGoogle Scholar
  44. 44.
    Yin W, Xu H, Sheng J, An Z, Guo S, Xie X, et al. Advantages of pure platelet-rich plasma compared with leukocyte- and platelet-rich plasma in treating rabbit knee osteoarthritis. Med Sci Monit. 2016;22:1280–90.  https://doi.org/10.12659/MSM.898218.CrossRefGoogle Scholar
  45. 45.
    Deasy B, Feduska J, Payne T, Li Y, Ambrosio F, Huard J. Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle. Mol Ther. 2009;17:1788–98.  https://doi.org/10.1038/mt.2009.136.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Filardo G, Kon E, Pereira Ruiz M, Vaccaro F, Guitaldi R, Di Martino A, et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc. 2011;20:2082–91.  https://doi.org/10.1007/s00167-011-1837-x.CrossRefPubMedGoogle Scholar
  47. 47.
    Hall MP, Band PA, Meislin RJ, Jazrawi LM, Cardone DA. Platelet-rich plasma: current concepts and application in sports medicine. J Am Acad Orthop Surg. 2009;17:602–8.CrossRefGoogle Scholar
  48. 48.
    Sundman E, Cole B, Fortier L. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med. 2011;39:2135–40.  https://doi.org/10.1177/0363546511417792.CrossRefPubMedGoogle Scholar
  49. 49.
    McCarrel T, Minas T, Fortier L. Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy. J Bone Joint Surg. 2012;94:e143.  https://doi.org/10.2106/JBJS.L.00019.CrossRefPubMedGoogle Scholar
  50. 50.
    Anitua E, Troya M, Zalduendo M, Orive G. The effect of different drugs on the preparation and biological outcomes of plasma rich in growth factors. Ann Anat. 2014;196:423–9.  https://doi.org/10.1016/j.aanat.2014.06.002.CrossRefGoogle Scholar
  51. 51.
    Boswell S, Cole B, Sundman E, Karas V, Fortier L. Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy. 2012;28:429–39.  https://doi.org/10.1016/j.arthro.2011.10.018.CrossRefPubMedGoogle Scholar
  52. 52.
    Braun H, Kim H, Chu C, Dragoo J. The effect of platelet-rich plasma formulations and blood products on human synoviocytes. Am J Sports Med. 2014;42:1204–10.  https://doi.org/10.1177/0363546514525593.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    • Meheux C, McCulloch P, Lintner D, Varner K, Harris J. Efficacy of intra-articular platelet-rich plasma injections in knee osteoarthritis: a systematic review. Arthroscopy. 2016;32:495–505.  https://doi.org/10.1016/j.arthro.2015.08.005 A recent systematic review focusing on level I evidence available for PRP treatment in KOA and indicating significant clinical improvements for up to 12 months post-injection. CrossRefPubMedGoogle Scholar
  54. 54.
    Bendinelli P, Matteucci E, Dogliotti G, Corsi M, Banfi G, Maroni P, et al. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-κB inhibition via HGF. J Cell Physiol. 2010;225:757–66.  https://doi.org/10.1002/jcp.22274.CrossRefPubMedGoogle Scholar
  55. 55.
    Scanzello C, Goldring S. The role of synovitis in osteoarthritis pathogenesis. Bone. 2012;51:249–57.  https://doi.org/10.1016/j.bone.2012.02.012.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Cavallo C, Filardo G, Mariani E, Kon E, Marcacci M, Pereira Ruiz M, et al. Comparison of platelet-rich plasma formulations for cartilage healing. J Bone Joint Surg Am. 2014;96:423–9.  https://doi.org/10.2106/JBJS.M.00726.CrossRefPubMedGoogle Scholar
  57. 57.
    Xu Z, Luo J, Huang X, Wang B, Zhang J, Zhou A. Efficacy of platelet-rich plasma in pain and self-report function in knee osteoarthritis. Am J Phys Med Rehabil. 2017;96:793–800.  https://doi.org/10.1097/PHM.0000000000000746.CrossRefPubMedGoogle Scholar
  58. 58.
    Muraglia A, Ottonello C, Spanò R, Dozin B, Strada P, Grandizio M, et al. Biological activity of a standardized freeze-dried platelet derivative to be used as cell culture medium supplement. Platelets. 2013;25:211–20.  https://doi.org/10.3109/09537104.2013.803529.CrossRefGoogle Scholar
  59. 59.
    Chien C, Ho H, Liang Y, Ko P, Sheu M, Chen C. Incorporation of exudates of human platelet-rich fibrin gel in biodegradable fibrin scaffolds for tissue engineering of cartilage. J Biomed Mater Res B Appl Biomater. 2012;100B:948–55.  https://doi.org/10.1002/jbm.b.32657.CrossRefGoogle Scholar
  60. 60.
    Wu C, Chen W, Zao B, Lai P, Lin T, Lo H, et al. Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokine-inhibited chondrogenesis. Biomaterials. 2011;32:5847–54.  https://doi.org/10.1016/j.biomaterials.2011.05.002.CrossRefGoogle Scholar
  61. 61.
    Spreafico A, Chellini F, Frediani B, Bernardini G, Niccolini S, Serchi T, et al. Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes. J Cell Biochem. 2009;108:1153–65.  https://doi.org/10.1002/jcb.22344.CrossRefGoogle Scholar
  62. 62.
    Akeda K, An H, Okuma M, Attawia M, Miyamoto K, Thonar E, et al. Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthr Cartil. 2006;14:1272–80.  https://doi.org/10.1016/j.joca.2006.05.008.CrossRefPubMedGoogle Scholar
  63. 63.
    Holmes H, Wilson B, Goerger J, Silverberg J, Cohen I, Zipfel W, et al. Facilitated recruitment of mesenchymal stromal cells by bone marrow concentrate and platelet rich plasma. PLoS One. 2018;13:e0194567.  https://doi.org/10.1371/journal.pone.0194567.CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Smyth N, Murawski C, Fortier L, Cole B, Kennedy J. Platelet-rich plasma in the pathologic processes of cartilage: review of basic science evidence. Arthroscopy. 2013;29:1399–409.  https://doi.org/10.1016/j.arthro.2013.03.004.CrossRefPubMedGoogle Scholar
  65. 65.
    Sakata R, McNary S, Miyatake K, Lee C, Van den Bogaerde J, Marder R, et al. Stimulation of the superficial zone protein and lubrication in the articular cartilage by human platelet-rich plasma. Am J Sports Med. 2015;43:1467–73.  https://doi.org/10.1177/0363546515575023.CrossRefPubMedPubMedCentralGoogle Scholar
  66. 66.
    Quicke J, Foster N, Thomas M, Holden M. Is long-term physical activity safe for older adults with knee pain?: a systematic review. Osteoarthr Cartil. 2015;23:1445–56.  https://doi.org/10.1016/j.joca.2015.05.002.CrossRefPubMedGoogle Scholar
  67. 67.
    Juhl C, Christensen R, Roos E, Zhang W, Lund H. Impact of exercise type and dose on pain and disability in knee osteoarthritis: a systematic review and meta-regression analysis of randomized controlled trials. Arthritis Rheum. 2014;66:622–36.  https://doi.org/10.1002/art.38290.CrossRefGoogle Scholar
  68. 68.
    Bricca A, Juhl C, Steultjens M, Wirth W, Roos E. Impact of exercise on articular cartilage in people at risk of, or with established, knee osteoarthritis: a systematic review of randomised controlled trials. Br J Sports Med. 2018.  https://doi.org/10.1136/bjsports-2017-098661.
  69. 69.
    Felson DT, Zhang Y, Anthony JM, Naimark Anderson JJ. Weight loss reduces the risk for symptomatic knee osteoarthritis in woman. The Framingham Study. Ann Intern Med. 1992;116:535–9.CrossRefGoogle Scholar
  70. 70.
    Laudy A, Bakker E, Rekers M, Moen M. Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis. Br J Sports Med. 2014;49:657–72.  https://doi.org/10.1136/bjsports-2014-094036.CrossRefPubMedGoogle Scholar
  71. 71.
    Lazaridou A, Martel M, Cornelius M, Franceschelli O, Campbell C, Smith M, et al. The association between daily physical activity and pain among patients with knee osteoarthritis: the moderating role of pain catastrophizing. Pain Medicine. 2018.  https://doi.org/10.1093/pm/pny129.
  72. 72.
    Baxter S, Hale L, Stebbings S, Gray A, Smith C, Treharne G. Walking is a feasible physical activity for people with rheumatoid arthritis: a feasibility randomized controlled trial. Musculoskeletal Care. 2015;14:47–56.  https://doi.org/10.1002/msc.1112.CrossRefPubMedGoogle Scholar
  73. 73.
    Harden R, Wallach G, Gagnon C, Zereshki A, Mukai A, Saracoglu M, et al. The osteoarthritis knee model: psychophysical characteristics and putative outcomes. J Pain. 2013;14:281–9.  https://doi.org/10.1016/j.jpain.2012.11.009.CrossRefPubMedGoogle Scholar
  74. 74.
    Rosemann T, Laux G, Szecsenyi J, Wensing M, Grol R. Pain and osteoarthritis in primary care: factors associated with pain perception in a sample of 1,021 patients. Pain Med. 2008;9:903–10.  https://doi.org/10.1111/j.1526-4637.2008.00498.x.CrossRefPubMedGoogle Scholar
  75. 75.
    Saccomanno M, Donati F, Careri S, Bartoli M, Severini G, Milano G. Efficacy of intra-articular hyaluronic acid injections and exercise-based rehabilitation programme, administered as isolated or integrated therapeutic regimens for the treatment of knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2015;24:1686–94.  https://doi.org/10.1007/s00167-015-3917-9.CrossRefPubMedGoogle Scholar
  76. 76.
    Campbell K, Saltzman B, Mascarenhas R, Khair M, Verma N, Bach B, et al. Does intra-articular platelet-rich plasma injection provide clinically superior outcomes compared with other therapies in the treatment of knee osteoarthritis? A systematic review of overlapping meta-analyses. Arthroscopy. 2015;31:2213–21.  https://doi.org/10.1016/j.arthro.2015.03.041.CrossRefPubMedGoogle Scholar
  77. 77.
    Clegg D, Reda D, Harris C, Klein M, O'Dell J, Hooper M, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354:795–808.  https://doi.org/10.1056/NEJMoa052771.CrossRefPubMedGoogle Scholar
  78. 78.
    Michael J, Schlüter-Brust K, Eysel P. The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee. Dtsch Arztebl Int. 2010;107(9):152–62.  https://doi.org/10.3238/arztebl.2010.0152.CrossRefPubMedPubMedCentralGoogle Scholar
  79. 79.
    Bert J, Bert T. Nonoperative treatment of unicompartmental arthritis. Clin Sports Med. 2014;33:1–10.  https://doi.org/10.1016/j.csm.2013.08.002.CrossRefPubMedGoogle Scholar
  80. 80.
    Simental-Mendía M, Vílchez-Cavazos J, Peña-Martínez V, Said-Fernández S, Lara-Arias J, Martínez-Rodríguez H. Leukocyte-poor platelet-rich plasma is more effective than the conventional therapy with acetaminophen for the treatment of early knee osteoarthritis. Arch Orthop Trauma Surg. 2016;136:1723–32.  https://doi.org/10.1007/s00402-016-2545-2.CrossRefPubMedGoogle Scholar
  81. 81.
    Osterman C, McCarthy M, Cote M, Beitzel K, Bradley J, Polkowski G, et al. Platelet-rich plasma increases anti-inflammatory markers in a human coculture model for osteoarthritis. Am J Sports Med. 2015;43:1474–84.  https://doi.org/10.1177/0363546515570463.CrossRefPubMedGoogle Scholar
  82. 82.
    Richards M, Maxwell J, Weng L, Angelos M, Golzarian J. Intra-articular treatment of knee osteoarthritis: from anti-inflammatories to products of regenerative medicine. Phys Sportsmed. 2016;44:101–8.  https://doi.org/10.1080/00913847.2016.1168272.CrossRefPubMedPubMedCentralGoogle Scholar
  83. 83.
    Jüni P, Hari R, Rutjes A, Fischer R, Silletta M, Reichenbach S et al. Intra-articular corticosteroid for knee osteoarthritis. Cochrane Database Syst Rev. 2015. Issue 10. Art. No.: CD005328.  https://doi.org/10.1002/14651858.CD005328.pub3.
  84. 84.
    MacMahon P, Eustace S, Kavanagh E. Injectable corticosteroid and local anesthetic preparations: a review for radiologists. Radiology. 2009;252:647–61.  https://doi.org/10.1148/radiol.2523081929.CrossRefPubMedGoogle Scholar
  85. 85.
    Raynauld J, Buckland-Wright C, Ward R, Choquette D, Haraoui B, Martel-Pelletier J, et al. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2003;48:370–7.  https://doi.org/10.1002/art.10777.CrossRefPubMedGoogle Scholar
  86. 86.
    McAlindon T, LaValley M, Harvey W, Price L, Driban J, Zhang M, et al. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis. JAMA. 2017;317:1967–75.  https://doi.org/10.1001/jama.2017.5283.CrossRefPubMedPubMedCentralGoogle Scholar
  87. 87.
    Joshi Jubert N, Rodríguez L, Reverté-Vinaixa M, Navarro A. Platelet-rich plasma injections for advanced knee osteoarthritis: a prospective, randomized, double-blinded clinical trial. Orthop J Sports Med. 2017;5(2):232596711668938.  https://doi.org/10.1177/2325967116689386.CrossRefGoogle Scholar
  88. 88.
    Forogh B, Mianehsaz E, Shoaee S, Ahadi T, Raissi GR, Sajadi S. Effect of single injection of platelet-rich plasma in comparison with corticosteroid on knee osteoarthritis: a double-blind randomized clinical trial. J Sports Med Phys Fitness. 2016;56(7–8):901–8.PubMedGoogle Scholar
  89. 89.
    Saltzman B, Leroux T, Meyer M, Basques B, Chahal J, Bach B, et al. The therapeutic effect of intra-articular normal saline injections for knee osteoarthritis: a meta-analysis of evidence level 1 studies. Am J Sports Med. 2016;45:2647–53.  https://doi.org/10.1177/0363546516680607.CrossRefPubMedGoogle Scholar
  90. 90.
    Vannabouathong C, Bhandari M, Bedi A, Khanna V, Yung P, Shetty V, et al. Nonoperative treatments for knee osteoarthritis. JBJS Reviews. 2018;6(7):e5.  https://doi.org/10.2106/JBJS.RVW.17.00167.CrossRefGoogle Scholar
  91. 91.
    Görmeli G, Görmeli C, Ataoglu B, Çolak C, Aslantürk O, Ertem K. Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: a randomized, double-blind, placebo-controlled trial. Knee Surg Sports Traumatol Arthrosc. 2015;25:958–65.  https://doi.org/10.1007/s00167-015-3705-6.CrossRefPubMedGoogle Scholar
  92. 92.
    Patel S, Dhillon M, Aggarwal S, Marwaha N, Jain A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis. Am J Sports Med. 2013;41:356–64.  https://doi.org/10.1177/0363546512471299.CrossRefPubMedGoogle Scholar
  93. 93.
    • Smith P. Intra-articular autologous conditioned plasma injections provide safe and efficacious treatment for knee osteoarthritis. Am J Sports Med. 2016;44:884–91.  https://doi.org/10.1177/0363546515624678 FDA-regulated, double-blind, placebo-controlled study demonstrating significantly greater improvements in patients treated with LP-PRP compared to saline up to 12 months. CrossRefPubMedGoogle Scholar
  94. 94.
    Duymus T, Mutlu S, Dernek B, Komur B, Aydogmus S, Kesiktas F. Choice of intra-articular injection in treatment of knee osteoarthritis: platelet-rich plasma, hyaluronic acid or ozone options. Knee Surg Sports Traumatol Arthrosc. 2016;25:485–92.  https://doi.org/10.1007/s00167-016-4110-5.CrossRefPubMedGoogle Scholar
  95. 95.
    • Cole B, Karas V, Hussey K, Merkow D, Pilz K, Fortier L. Hyaluronic acid versus platelet-rich plasma: a prospective, double-blind randomized controlled trial comparing clinical outcomes and effects on intra-articular biology for the treatment of knee osteoarthritis. Am J Sports Med. 2016;45:339–46.  https://doi.org/10.1177/0363546516665809 Demonstrated increased efficacy of LP-PRP compared to HA in regards to patient-reported outcomes, and demonstrated a trend toward decreased inflammatory cytokines in LP-PRP compared to HA at 12 weeks. CrossRefPubMedGoogle Scholar
  96. 96.
    Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl. 1993;39:3–9.PubMedGoogle Scholar
  97. 97.
    Cerza F, Carnì S, Carcangiu A, Di Vavo I, Schiavilla V, Pecora A, et al. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med. 2012;40:2822–7.  https://doi.org/10.1177/0363546512461902.CrossRefPubMedGoogle Scholar
  98. 98.
    Vaquerizo V, Plasencia M, Arribas I, Seijas R, Padilla S, Orive G, et al. Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial. Arthroscopy. 2013;29:1635–43.  https://doi.org/10.1016/j.arthro.2013.07.264.CrossRefGoogle Scholar
  99. 99.
    Ahmad H, Farrag S, Okasha A, Kadry A, Ata T, Monir A, et al. Clinical outcomes are associated with changes in ultrasonographic structural appearance after platelet-rich plasma treatment for knee osteoarthritis. Int J Rheum Dis. 2018;21:960–6.  https://doi.org/10.1111/1756-185X.13315.CrossRefPubMedGoogle Scholar
  100. 100.
    Louis M, Magalon J, Jouve E, Bornet C, Mattei J, Chagnaud C, et al. Growth factors levels determine efficacy of platelets rich plasma injection in knee osteoarthritis: a randomized double blind noninferiority trial compared with viscosupplementation. Arthroscopy. 2018;34:1530–1540.e2.  https://doi.org/10.1016/j.arthro.2017.11.035.CrossRefPubMedGoogle Scholar
  101. 101.
    Montañez-Heredia E, Irízar S, Huertas P, Otero E, del Valle M, Prat I, et al. Intra-articular injections of platelet-rich plasma versus hyaluronic acid in the treatment of osteoarthritic knee pain: a randomized clinical trial in the context of the Spanish National Health Care System. Int J Mol Sci. 2016;17:1064.  https://doi.org/10.3390/ijms17071064.CrossRefGoogle Scholar
  102. 102.
    Raeissadat S, Rayegani S, Hassanabadi H, Fathi M, Ghorbani E, Babaee M, et al. Knee osteoarthritis injection choices: platelet- rich plasma (PRP) versus hyaluronic acid (a one-year randomized clinical trial). Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders. 2015;8:1–8.  https://doi.org/10.4137/CMAMD.S17894.CrossRefPubMedGoogle Scholar
  103. 103.
    Filardo G, Di Matteo B, Di Martino A, Merli M, Cenacchi A, Fornasari P, et al. Platelet-rich plasma intra-articular knee injections show no superiority versus viscosupplementation. Am J Sports Med. 2015;43:1575–82.  https://doi.org/10.1177/0363546515582027.CrossRefPubMedGoogle Scholar
  104. 104.
    Sánchez M, Fiz N, Azofra J, Usabiaga J, Aduriz Recalde E, Garcia Gutierrez A, et al. A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy. 2012;28:1070–8.  https://doi.org/10.1016/j.arthro.2012.05.011.CrossRefGoogle Scholar
  105. 105.
    Sampson S, Reed M, Silvers H, Meng M, Mandelbaum B. Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis. Am J Phys Med Rehabil. 2010;89:961–9.  https://doi.org/10.1097/PHM.0b013e3181fc7edf.CrossRefPubMedGoogle Scholar
  106. 106.
    Filardo G, Kon E, DI Matteo B, DI Marino A, Sessa A, Merli ML, et al. Leukocyte-poor PRP application for the treatment of knee osteoarthritis. Joints. 2014;1(3):112–20 eCollection 2013 Jul-Sep.Google Scholar
  107. 107.
    Hurley E, Yasui Y, Gianakos A, Seow D, Shimozono Y, Kerkhoffs G, et al. Limited evidence for adipose-derived stem cell therapy on the treatment of osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2018.  https://doi.org/10.1007/s00167-018-4955-x.CrossRefGoogle Scholar
  108. 108.
    Chahla J, Piuzzi N, Mitchell J, Dean C, Pascual-Garrido C, LaPrade R, et al. Intra-articular cellular therapy for osteoarthritis and focal cartilage defects of the knee. J Bone Joint Surg. 2016;98:1511–21.  https://doi.org/10.2106/JBJS.15.01495.CrossRefPubMedGoogle Scholar
  109. 109.
    Pas H, Winters M, Haisma H, Koenis M, Tol J, Moen M. Stem cell injections in knee osteoarthritis: a systematic review of the literature. Br J Sports Med. 2017;51:1125–33.  https://doi.org/10.1136/bjsports-2016-096793.CrossRefPubMedGoogle Scholar
  110. 110.
    Koh Y, Choi Y. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee. 2012;19:902–7.  https://doi.org/10.1016/j.knee.2012.04.001.CrossRefPubMedGoogle Scholar
  111. 111.
    Kim J, Lee G, Jung G, Kim C, Kim T, Park J, et al. Clinical outcome of autologous bone marrow aspirates concentrate (BMAC) injection in degenerative arthritis of the knee. European Journal of Orthopaedic Surgery & Traumatology. 2014;24:1505–11.  https://doi.org/10.1007/s00590-013-1393-9.CrossRefGoogle Scholar
  112. 112.
    Centeno C, Pitts J, Al-Sayegh H, Freeman M. Efficacy of autologous bone marrow concentrate for knee osteoarthritis with and without adipose graft. Biomed Res Int. 2014;2014:1–9.  https://doi.org/10.1155/2014/370621.CrossRefGoogle Scholar
  113. 113.
    Shaw B, Darrow M, Derian A. Short-term outcomes in treatment of knee osteoarthritis with 4 bone marrow concentrate injections. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders. 2018;11:117954411878108.  https://doi.org/10.1177/1179544118781080.CrossRefGoogle Scholar
  114. 114.
    • Shapiro S, Kazmerchak S, Heckman M, Zubair A, O’Connor M. A prospective, single-blind, placebo-controlled trial of bone marrow aspirate concentrate for knee osteoarthritis. Am J Sports Med. 2016;45:82–90.  https://doi.org/10.1177/0363546516662455 Placebo-controlled trial finding no significant improvement between patients treated with saline and BMAC in KOA. CrossRefPubMedGoogle Scholar
  115. 115.
    Piuzzi NS, Ng M, Chughtai M, Khlopas A, Ng K, Mont MA, et al. The stem-cell market for the treatment of knee osteoarthritis: a patient perspective. J Knee Surg. 2018;31(6):551–6.  https://doi.org/10.1055/s-0037-1604443.CrossRefGoogle Scholar
  116. 116.
    • Chahla J, Cinque M, Piuzzi N, Mannava S, Geeslin A, Murray I, et al. A call for standardization in platelet-rich plasma preparation protocols and composition reporting. J Bone Joint Surg Am. 2017;99:1769–79.  https://doi.org/10.2106/JBJS.16.01374 An important statement to researchers involving the importance of standardization in PRP protocols, methods, and reporting. CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Columbia Orthopaedic GroupColumbiaUSA
  2. 2.Department of Orthopaedic SurgeryUniversity of MissouriColumbiaUSA

Personalised recommendations